User profiles for Vladimir Gilca

Vladimir Gilca

Institut national de santé publique
Verified email at inspq.qc.ca
Cited by 2543

[HTML][HTML] Protection against omicron (B. 1.1. 529) BA. 2 reinfection conferred by primary omicron BA. 1 or pre-omicron SARS-CoV-2 infection among health-care …

…, C Sauvageau, N Brousseau, R Gilca… - The Lancet Infectious …, 2023 - thelancet.com
Background There is a paucity of data on vaccine-induced or infection-induced (hybrid or
natural) immunity against omicron (B.1.1.529) subvariant BA.2, particularly in comparing the …

Estimated protection of prior SARS-CoV-2 infection against reinfection with the Omicron variant among messenger RNA–vaccinated and nonvaccinated individuals in …

…, C Sauvageau, N Brousseau, R Gilca… - JAMA network …, 2022 - jamanetwork.com
Importance The Omicron variant is phylogenetically and antigenically distinct from earlier
SARS-CoV-2 variants and the original vaccine strain. Protection conferred by prior SARS-CoV-…

[HTML][HTML] Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada

C Sauvageau, B Duval, V Gilca, F Lavoie, M Ouakki - BMC Public Health, 2007 - Springer
Background The Pap test has been used for cervical cancer screening for more than four
decades. A human papillomavirus (HPV) vaccine has been approved for use in Canada and is …

Parents' decision-making about the human papillomavirus vaccine for their daughters: I. Quantitative results

A Krawczyk, B Knäuper, V Gilca, E Dubé… - Human vaccines & …, 2015 - Taylor & Francis
Vaccination against the human papillomavirus (HPV) is an effective primary prevention
measure for HPV-related diseases. For children and young adolescents, the uptake of the …

Cervical cancer prevention by vaccination: nurses' knowledge, attitudes and intentions

B Duval, V Gilca, N Boulianne, K Pielak… - Journal of advanced …, 2009 - Wiley Online Library
Vladimir Gilca Vladimir Gilca PhD MD Medical Epidemiologist Quebec National Public Health
Vladimir Gilca PhD MD Medical Epidemiologist Quebec National Public Health Institute, …

Impact of an immunization campaign to control an increased incidence of serogroup B meningococcal disease in one region of Quebec, Canada

…, D Law, G De Serres, V Gilca, R Gilca… - Clinical infectious …, 2017 - academic.oup.com
Background. Invasive meningococcal disease (IMD) incidence increased in Quebec, starting
in 2003, and was caused by a serogroup B sequence type 269 clone. The Saguenay-Lac-…

Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v)

…, G De Serres, D Purych, V Gilca… - The Journal of …, 2012 - academic.oup.com
Background. Cases of infection due to a novel swine-origin variant of influenza A virus
subtype H3N2 (H3N2v) have recently been identified in the United States, primarily among …

Protection against Omicron re-infection conferred by prior heterologous SARS-CoV-2 infection, with and without mRNA vaccination

…, M Brisson, C Sauvageau, N Brousseau, R Gilca… - medRxiv, 2022 - medrxiv.org
Importance Omicron is phylogenetically- and antigenically-distinct from earlier SARS-CoV-2
variants and the original vaccine strain. Protection conferred by prior SARS-CoV-2 infection …

Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs

B Duval, V Gilca, S McNeil, S Dobson, D Money… - Vaccine, 2007 - Elsevier
We assessed Canadian obstetrician/gynaecologists’, family physicians’ and paediatricians’
knowledge, attitudes, and beliefs about HPV infection and prevention, as well as factors …

Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination …

…, AC Tricco, CT Bauch, B Pham, V Gilca… - …, 2008 - Springer
Cost-effectiveness/cost-utility studies of hepatitis A vaccine were identified via a series of
literature searches (MEDLINE, EMBASE, HSTAR and SSCI). Citations and full-text articles were …